Brief: AstraZeneca PLC Announces Trixeo Approved In EU For Asthma
23/09/2026 07:31
BRIEF-AstraZeneca PLC Announces Trixeo Approved In EU For Asthma Sept 23 (Reuters) - AstraZeneca PLC AZN.L:
ASTRAZENECA PLC - TRIXEO APPROVED IN EU FOR ASTHMA
ASTRAZENECA PLC - TRIXEO APPROVED IN EU FOR ASTHMA
ASTRAZENECA - TRIXEO APPROVED IN EU FOR MAINTENANCE TREATMENT OF ASTHMA
Source text: ID:nRSW8647Va
Further company coverage: AZN.L
((Reuters.Briefs@thomsonreuters.com;))
Recent news on AstraZeneca
See all newsAstraZeneca says FDA approves drug for rare kidney disease in adults
AstraZeneca-Amgen asthma drug hits 69% remission in esophageal disease trial
Early US flu season, current strain may signal risk for younger people; doctors urge shots
AstraZeneca partners with Oracle for AI-driven clinical trials
Factbox: Pharma sector doubles down on AI to slash costs, timelines